Anti-Inflammatory and Anti-Oxidative Synergistic Effect of Vitamin D and Nutritional Complex on Retinal Pigment Epithelial and Endothelial Cell Lines against Age-Related Macular Degeneration.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
23 Apr 2021
Historique:
received: 18 02 2021
revised: 08 04 2021
accepted: 21 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 27 5 2021
Statut: epublish

Résumé

Age-related macular degeneration (AMD) is a multifactorial disease of the retina featured by dysfunction of retinal pigmented epithelial (RPE) and loss of photoreceptor cells under oxidative stress and inflammatory conditions. Vitamin D and antioxidants have beneficial effects against retinal degenerative diseases, such as AMD. We investigated the impact of associating vitamin D (ND) with a nutritional antioxidant complex (Nutrof Total

Identifiants

pubmed: 33922669
pii: nu13051423
doi: 10.3390/nu13051423
pmc: PMC8170899
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antioxidants 0
Cytokines 0
Vitamin D 1406-16-2
8-Hydroxy-2'-Deoxyguanosine 88847-89-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Expert Rev Mol Med. 2010 Oct 20;12:e34
pubmed: 20959033
Arch Ophthalmol. 2007 May;125(5):661-9
pubmed: 17502506
Nutrients. 2017 Oct 13;9(10):
pubmed: 29027953
Arch Ophthalmol. 1995 Jun;113(6):743-8
pubmed: 7786215
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):4
pubmed: 32031576
Antioxidants (Basel). 2020 Sep 08;9(9):
pubmed: 32911690
J Nutr Health Aging. 2017;21(7):772-780
pubmed: 28717807
Invest Ophthalmol Vis Sci. 2007 May;48(5):2327-34
pubmed: 17460298
Int J Ophthalmol. 2014 Apr 18;7(2):293-301
pubmed: 24790873
PLoS Med. 2006 Aug;3(8):e364
pubmed: 16903781
Arch Ophthalmol. 1994 Jul;112(7):932-7
pubmed: 8031273
Invest Ophthalmol Vis Sci. 2014 Apr 07;55(4):2140-7
pubmed: 24576880
Ophthalmology. 2013 Apr;120(4):844-51
pubmed: 23332590
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4569-4578
pubmed: 28892825
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
Invest Ophthalmol Vis Sci. 2014 Jul 11;55(8):4823-31
pubmed: 25015360
Am J Ophthalmol. 2004 Mar;137(3):486-95
pubmed: 15013873
Oman Med J. 2020 Jan 5;35(1):e83
pubmed: 31993223
Inflamm Allergy Drug Targets. 2009 Mar;8(1):40-52
pubmed: 19275692
Sci Rep. 2016 Oct 04;6:33083
pubmed: 27698364
Mol Endocrinol. 2011 Feb;25(2):360-72
pubmed: 21239617
Mol Vis. 2008;14:2292-303
pubmed: 19093006
Oxid Med Cell Longev. 2016;2016:1908164
pubmed: 27375834
Antioxid Redox Signal. 2009 Nov;11(11):2655-71
pubmed: 19558209
Br J Ophthalmol. 2008 Apr;92(4):537-40
pubmed: 18310311
Joint Bone Spine. 2010 Dec;77(6):552-7
pubmed: 21067953
Oxid Med Cell Longev. 2020 Feb 10;2020:7901270
pubmed: 32104539
Front Immunol. 2019 Jul 16;10:1618
pubmed: 31379825
Rom J Ophthalmol. 2015 Apr-Jun;59(2):74-7
pubmed: 26978865
Eye (Lond). 2018 Mar;32(3):491-505
pubmed: 29171506
J Pathol. 2017 Jan;241(1):45-56
pubmed: 27701734
Eur J Immunol. 2014 Nov;44(11):3320-9
pubmed: 25116404
Redox Biol. 2014 Feb 23;2:535-62
pubmed: 24634836
PLoS One. 2015 May 15;10(5):e0125150
pubmed: 25978536
Lancet. 2018 Sep 29;392(10153):1147-1159
pubmed: 30303083
Int J Mol Sci. 2018 Jun 20;19(6):
pubmed: 29925789
Arch Ophthalmol. 2011 Apr;129(4):481-9
pubmed: 21482873
Arq Bras Oftalmol. 2020 Aug;83(4):312-317
pubmed: 32756790
Nat Rev Clin Oncol. 2009 Jun;6(6):315-26
pubmed: 19483738
Redox Biol. 2017 Oct;13:1-7
pubmed: 28528123
Int J Mol Sci. 2018 Dec 03;19(12):
pubmed: 30513885
JAMA. 2013 May 15;309(19):2005-15
pubmed: 23644932
Lancet. 2012 May 5;379(9827):1728-38
pubmed: 22559899
Antioxidants (Basel). 2019 Aug 24;8(9):
pubmed: 31450606
Arch Ophthalmol. 2001 Oct;119(10):1417-36
pubmed: 11594942
Mol Vis. 2016 Oct 08;22:1156-1168
pubmed: 27733811
Endocrinol Metab Clin North Am. 2010 Jun;39(2):365-79, table of contents
pubmed: 20511058
Curr Eye Res. 2009 Dec;34(12):1089-93
pubmed: 19958129
Arch Ophthalmol. 1992 Jan;110(1):99-104
pubmed: 1731731
J Nutr. 2015 Aug;145(8):1865-72
pubmed: 26084364
Exp Eye Res. 2015 May;134:101-10
pubmed: 25724179
J Nutr. 2004 Nov;134(11):3179S-3180S
pubmed: 15514296
Biochim Biophys Acta. 2016 Dec;1863(12):2977-2992
pubmed: 27646922
J Nutr. 2002 Mar;132(3):518S-524S
pubmed: 11880585
Curr Eye Res. 2001 Mar;22(3):165-73
pubmed: 11462152
Ocul Immunol Inflamm. 2020 Oct 13;:1-8
pubmed: 33048602
Open Neurol J. 2016 Aug 31;10:83-7
pubmed: 27651846
Eye (Lond). 2011 Sep;25(9):1122-9
pubmed: 21818133
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009 Apr;27(2):120-39
pubmed: 19412858
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1362-1371
pubmed: 30934055
Int J Ophthalmol. 2017 Apr 18;10(4):507-514
pubmed: 28503420
Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
pubmed: 11033038
J Diabetes Res. 2018 Feb 22;2018:8193523
pubmed: 29682582
Hum Genomics. 2011 Oct;5(6):538-68
pubmed: 22155603
Arch Ophthalmol. 2010 Jun;128(6):750-8
pubmed: 20547953
Cell Biochem Funct. 2016 Mar;34(2):82-94
pubmed: 26890033
Eur J Endocrinol. 2001 Sep;145(3):351-7
pubmed: 11517017
Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H753-H765
pubmed: 29351464
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):675-84
pubmed: 14744914
Mol Med Rep. 2018 May;17(5):7301-7306
pubmed: 29568872
J Investig Med. 2011 Aug;59(6):881-6
pubmed: 21527855
Apoptosis. 2012 Nov;17(11):1144-55
pubmed: 22911474
Arch Ophthalmol. 2012 Aug;130(8):1070-1
pubmed: 22893083
Exp Cell Res. 2020 Jul 1;392(1):112023
pubmed: 32325079
Maturitas. 2016 Jun;88:101-12
pubmed: 27105707
Sci Rep. 2016 Feb 05;6:20723
pubmed: 26846575
Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):699-704
pubmed: 25056526
Arch Ophthalmol. 2001 Aug;119(8):1191-9
pubmed: 11483088
Nat Med. 2012 May;18(5):791-8
pubmed: 22484808
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):202-208
pubmed: 30644965
PLoS One. 2015 Jun 24;10(6):e0130395
pubmed: 26107738
J Ophthalmol. 2014;2014:582842
pubmed: 25478207
Int J Ophthalmol. 2018 Oct 18;11(10):1594-1599
pubmed: 30364251
Arch Ophthalmol. 2002 Oct;120(10):1357-63
pubmed: 12365915
Curr Eye Res. 1995 Feb;14(2):101-8
pubmed: 7539352
J Cell Biol. 1995 Apr;129(2):507-19
pubmed: 7536748

Auteurs

Maria Hernandez (M)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.
Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.

Sergio Recalde (S)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.
Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.

Jorge González-Zamora (J)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.

Valentina Bilbao-Malavé (V)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.

Manuel Sáenz de Viteri (M)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.
Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.

Jaione Bezunartea (J)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.

Maite Moreno-Orduña (M)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.

Idoia Belza (I)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.

Jesús Barrio-Barrio (J)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.

Patricia Fernandez-Robredo (P)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.
Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.

Alfredo García-Layana (A)

Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.
Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH